| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Psychiatry and Psychotherapy (Drs. Jessen, Heun, and Papassotiropoulos) and Radiology (Drs. Block, Träber, Keller, Flacke, and Schild), University of Bonn, Germany; and Philips Medical Systems (Dr. Lamerichs), Best, the Netherlands.
Address correspondence and reprint requests to Dr. Frank Jessen, Department of Psychiatry and Psychotherapy, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany; e-mail: jessen{at}uni-bonn.de
BACKGROUND: The reduction of N-acetylaspartate (NAA) detected by proton MR spectroscopy (1H-MRS) represents a robust but unspecific marker for neuronal loss or dysfunction.
OBJECTIVE: To apply 1H-MRS in two brain regions that reflect the characteristic spatial distribution of neuronal loss in AD. These regions are the medial temporal lobe (MTL), which is affected early in AD, and the primary motor and sensory cortex (central region), which is affected late in the disease and might serve as an intraindividual control region in mild to moderate disease stages.
METHODS: Twenty patients and 18 volunteers underwent 1H-MRS in both brain areas. The metabolic ratios of NAA/creatine and choline/creatine were determined. Additionally, the metabolic ratios of the MTL were divided by the ratios of the central region to assess the relative change in the MTL in individual subjects. All ratios were correlated with psychometric test scores.
RESULTS: A significant reduction of NAA/creatine and choline/creatine ratios was detected in the MTL of patients with AD. In the central region, no significant difference between the groups was found. NAA/creatine (MTL/central region) was reduced in patients with AD and showed a correlation with the Mini-Mental State Examination and the cognitive part of the Alzheimer Disease Assessment Scale scores. Choline/creatine (MTL/central region) did not show a significant difference between groups.
CONCLUSION: Assessing the distribution of NAA/creatine reduction guided by the expected neuropathologic change can improve the role of 1H-MRS in the assessment of AD. The disease severity can be monitored by relative reduction of NAA/creatine in the MTL in comparison with an intraindividual unaffected control region.
This article has been cited by other articles:
|
|
 |
|
  K. Kantarci, R. C. Petersen, S. A. Przybelski, S. D. Weigand, M. M. Shiung, J. L. Whitwell, S. Negash, R. J. Ivnik, B. F. Boeve, D. S. Knopman, et al. Hippocampal Volumes, Proton Magnetic Resonance Spectroscopy Metabolites, and Cerebrovascular Disease in Mild Cognitive Impairment Subtypes Arch Neurol, December 1, 2008; 65(12): 1621 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kantarci, D. S. Knopman, D. W. Dickson, J. E. Parisi, J. L. Whitwell, S. D. Weigand, K. A. Josephs, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr Alzheimer Disease: Postmortem Neuropathologic Correlates of Antemortem 1H MR Spectroscopy Metabolite Measurements Radiology, July 1, 2008; 248(1): 210 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K KANTARCI 1H Magnetic resonance spectroscopy in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S146 - S152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Minati, M. Grisoli, and M. G. Bruzzone MR Spectroscopy, Functional MRI, and Diffusion-Tensor Imaging in the Aging Brain: A Conceptual Review J Geriatr Psychiatry Neurol, March 1, 2007; 20(1): 3 - 21. [Abstract] [PDF]
|
|
|
|
 |
|
 T. den Heijer, P. E. Sijens, N. D. Prins, A. Hofman, P. J. Koudstaal, M. Oudkerk, and M.M.B. Breteler MR spectroscopy of brain white matter in the prediction of dementia Neurology, February 28, 2006; 66(4): 540 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kantarci, R. C. Petersen, B. F. Boeve, D. S. Knopman, D. F. Tang-Wai, P. C. O'Brien, S. D. Weigand, S. D. Edland, G. E. Smith, R. J. Ivnik, et al. 1H MR spectroscopy in common dementias Neurology, October 26, 2004; 63(8): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Petrella, R. E. Coleman, and P. M. Doraiswamy Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future Radiology, February 1, 2003; 226(2): 315 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Dixon, K. M. Bradley, M. M. Budge, P. Styles, and A. D. Smith Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease Brain, October 1, 2002; 125(10): 2332 - 2341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Summerfield, B. Gomez-Anson, E. Tolosa, J. M. Mercader, M. J. Marti, P. Pastor, and C. Junque Dementia in Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study Arch Neurol, September 1, 2002; 59(9): 1415 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chantal, M. Labelle, R. W. Bouchard, C. M. J. Braun, and Y. Boulanger Correlation of Regional Proton Magnetic Resonance Spectroscopic Metabolic Changes With Cognitive Deficits in Mild Alzheimer Disease Arch Neurol, June 1, 2002; 59(6): 955 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Block, F. Jessen, F. Traber, S. Flacke, C. Manka, R. Lamerichs, E. Keller, R. Heun, and H. Schild Regional N-Acetylaspartate Reduction in the Hippocampus Detected With Fast Proton Magnetic Resonance Spectroscopic Imaging in Patients With Alzheimer Disease Arch Neurol, May 1, 2002; 59(5): 828 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Schuff, A. A. Capizzano, A. T. Du, D. L. Amend, J. O'Neill, D. Norman, J. Kramer, W. Jagust, B. Miller, O. M. Wolkowitz, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD Neurology, March 26, 2002; 58(6): 928 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Maneru, C. Junque, N. Bargallo, M. Olondo, F. Botet, M. Tallada, J. Guardia, and J. M. Mercader 1H-MR spectroscopy is sensitive to subtle effects of perinatal asphyxia Neurology, September 25, 2001; 57(6): 1115 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Jessen, W. Block, F. Traber, E. Keller, S. Flacke, R. Lamerichs, H. H. Schild, and R. Heun Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients Neurology, September 11, 2001; 57(5): 930 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Valenzuela and P. Sachdev Magnetic resonance spectroscopy in AD Neurology, March 13, 2001; 56(5): 592 - 598. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
